CVS Health Raises Full-Year Outlook After Strong Earnings Beat and Eli Lilly Weight-Loss Drug Deal
CVS Health Raises Full-Year Outlook After Strong Earnings Beat and Eli Lilly Weight-Loss Drug Deal CVS Health surprised Wall Street with stronger-than-expected second-quarter results, boosted its full-year earnings guidance, and unveiled a strategic partnership with Eli Lilly that could strengthen its position in the fast-growing weight-loss drug market. The combination of improving insurance performance, solid...
Kyle
Aug 5, 2026
3 min Read
